Projects
Transcriptome-based management of transplant-related pulmonary fibrosis in chronic pulmonary rejection after lung or allogeneic stem cell transplantation KU Leuven
Background
Chronic lung allograft dysfunction (CLAD) and chronic pulmonary
graft-versus-host disease (cGvHD) are life-threatening conditions
commonly encountered respectively after lung transplantation and
allogeneic hematopoietic stem cell transplantation.
Pathophysiological and molecular pathways associated with
transplant-related pulmonary fibrosis, leading to structural changes
and lung failure, in CLAD ...
Host proteases at the interface between humans and SARS-CoV-2: Focus on TMPRSS2 as a therapeutic target. University of Antwerp
Evaluation of molecular point-of-care Xpert® Xpress SARS-CoV-2 detection implementation in resource limited settings (EXPERT-CoV2). University of Antwerp
SARS-coV2 variants evaluation in pregnancy and paediatrics cohorts (VERDI). University of Antwerp
SARS-coV2 variants Evaluation in pRegnancy and paeDIatrics cohorts Hasselt University
SARS-COV-2 Nursing Home study KU Leuven
Major study goals are to access the current seroprevalence of SARS-Cov-2 in nursing home (NH) residents and staff in Belgium with subsequent monthly follow-up of the sero-incidence over a period of 10 months. Our secondary study goal is to gain additional insights on the association between seropositivity, clinical manifestation and COVID-19 disease outcome.
Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolution Ghent University
Little more than a year since the start of the COVID-19 pandemic, we are just beginning to understand how SARS-CoV-2 can overcome host cell entry barriers, outsmart the human immune response, and will evolve in the wake of increasing herd immunity. A major concern is the emergence of variants, which escape immune barriers gradually established through ongoing vaccination campaigns. Another major conundrum of SARSCoV- 2 infections is the very ...
Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolution KU Leuven
Little more than a year since the start of the COVID-19 pandemic, we are just beginning to understand how
SARS-CoV-2 can overcome host cell entry barriers, outsmart the human immune response, and will evolve in
the wake of increasing herd immunity. A major concern is the emergence of variants, which escape immune
barriers gradually established through ongoing vaccination campaigns. Another major conundrum of SARSCoV-
2 ...